Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124168) titled 'Hepatitis B vaccination in post-liver transplant patients' on May 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Youan Hospital, Capital Medical University
Condition:
hepatitis B-related liver disease (cirrhosis, liver cancer, liver failure, etc.)
Intervention:
Test group (booster vaccine group):Recombinant Hepatitis B Vaccine 60ug for vaccination
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2024-10-17
Target Sample Size: Test group (booster vaccine group):89;Control group (routine vaccine group):89;
Countries of Recruitment:
China
To know ...